Categories: NewsSeniors

Sienna Announces August Dividend

MARKHAM, Ontario, Aug. 15, 2023 (GLOBE NEWSWIRE) — Sienna Senior Living Inc. (“Sienna” or the “Company”) (TSX: SIA) today announced a dividend of $0.078 per common share of the Company (each, a “Common Share”) for the month of August 2023, representing $0.936 per Common Share on an annualized basis.

The dividend will be payable on September 15, 2023 to shareholders of record as at August 31, 2023.  

The Company’s dividends are designated as eligible dividends for Canadian tax purposes in accordance with subsection 89(14) of the Income Tax Act (Canada), and any applicable corresponding provincial and territorial legislation.

About Sienna Senior Living

Sienna Senior Living Inc. (TSX:SIA) offers a full range of seniors’ living options, including independent living and assisted living under its Aspira retirement brand, long-term care, and specialized programs and services. Sienna’s approximately 12,000 employees are passionate about cultivating happiness in daily life. For more information, please visit  www.siennaliving.ca.

For further information, please contact:
David Hung
Chief Financial Officer & Executive Vice President
(905) 489-0258
david.hung@siennaliving.ca

Staff

Recent Posts

RealTime eClinical Solutions Appoints Jeff Kozloff as Chief Executive Officer to Accelerate Next Phase of Growth and Innovation

SAN ANTONIO, Jan. 12, 2026 /PRNewswire/ -- RealTime eClinical Solutions, a leader in clinical research…

1 second ago

HealthDyne Helps Advance Access to Obesity Treatment by Supporting New Carve-Out Benefit Options

HealthDyne will help expand access to obesity management medication through pharmacy support for carve-out weight…

12 seconds ago

FirmTech Expands Global Distribution Network, Advancing Its Growth as a Worldwide Sexual Health & Wellness Company

New distribution partnerships across Asia, Europe, and the Middle East help meet rising international demand…

18 seconds ago

MediKarma Launches Healthcare’s First “Agentic AI” Licensing Model: Opens Access to Validated Disease Management Agents

MediKarma is the "Intel Inside" of the healthcare economy. Payers and platforms can now license…

27 seconds ago

Using Recombinant Insulin and Trypsin for Safer Vaccine Production, Upcoming Webinar Hosted by Xtalks

In this free webinar, learn how recombinant insulin improves viral production across diverse vaccine platforms.…

40 seconds ago

Caris Life Sciences Announces Preliminary Fourth Quarter and Full Year 2025 Results

Full year revenue growth of approximately 94% driven by strong performance  in molecular profiling servicesIRVING,…

48 seconds ago